跳至主要内容
临床试验/NL-OMON56374
NL-OMON56374招募中不适用

Establishing colonisation with non-toxigenic Clostridioides difficile in healthy volunteers. - CloDiCo

eids Universitair Medisch Centrum0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Subject is aged >= 18 and <= 45 years and in good health.
  • 2. Subject has adequate understanding of the procedures of the study and is
  • able and willing to abide strictly thereby.
  • 3. For female subjects: subject agrees to use adequate contraception and not to
  • breastfeed for the duration of study.
  • 4. Subject has signed informed consent.

排除标准

  • 1. Any physical or psychiatric illness or conditions that could threaten or
  • compromise the health of the subject during the study, influence their ability
  • to participate in the trial or interfere with the interpretation of the study
  • results, as determined by the trial physician.
  • 2. Use of antibiotics (or other microbiota influencing products) within three
  • months prior to inclusion.
  • 3. Known immunosuppressive condition, including infection with Human
  • Immunodeficiency Virus (HIV), use of systemic corticosteroids or other immune
  • modifying drugs (with exception of antihistamines and topical steroids).
  • 4. Regular use (defined by more than once weekly) of proton-pump inhibitors or
  • H2- blockers during one month prior to inclusion.
  • 5. The use of strong P-glycoprotein-inhibitors (like ciclosporin, ketoconazole,
  • erythromycin, clarithromycin, verapamil and amiodaron).
  • 6. Known allergy to vancomycin, metronidazole or fidaxomicin.
  • 7. Known allergy to glycerol.
  • 8. Known immunodeficiency disorders.
  • 9. Known gastro-intestinal disease including but not limited to inflammatory
  • bowel diseases (Crohn*s disease, Colitis Ulcerosa), recent gastro-intestinal
  • surgery, constipation defined by bowel movements less than every second day.
  • 10. Positive fecal PCR with Clostridiodes or SSYC (Salmonella, Shigella,
  • Yersinia or Campylobacter spp.) at screening.
  • 11. Any condition that would put household members at a greater risk for
  • transmission e.g. no access or use of flush toilet, household members belonging
  • to vulnerable populations such as persons who are immunocompromised, children
  • younger than 2 years of age and elderly older than 70 years of age.
  • 12. For women of child bearing potential: a positive urine pregnancy test
  • before inclusion or lactating at screening / during the trial.
  • 13. Being an employee or student of the Experimental bacteriology group or the
  • controlled human infection center at LUMC.

研究者

相似试验